Pseudogene lncRNAs regulate cancer stem cell behavior and signaling
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, and resistance to…
EVA1A regulates fatty acid transporter CD36 in fatty liver disease
Metabolic Dysfunction-Associated Steatotic Liver Disease（MASLD） is characterized by excessive accumulation of lipids in hepatocytes and is closely associated…
How GLP-1 drugs affect the body beyond weight loss and glucose control
Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks,…
University of Missouri launches first on-campus radiopharmaceutical clinical trial
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
Single-cell study reveals how HPV shapes immune landscape in penile cancer
Although penile cancer represents less than 1% of male malignancies, it carries substantial physical and psychological burden, with…
EU Reform Aims to Fast-Track Cancer Drug Access
At the European Society for Medical Oncology (ESMO) Annual Meeting 2025, held recently in Berlin, experts presented an…
New NIH grants fuel research in oral cancer treatment and pain relief
Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
TROP2 identified as a promising therapeutic target for renal medullary carcinoma
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and…
Study reports the world’s first genetically engineered pig-to-human liver xenotransplantation
An important new study in the Journal of Hepatology, published by Elsevier, reports the world’s first auxiliary liver…
Next-generation imaging promises sharper, deeper view of living tissues
A University of Arizona research team will receive nearly $2.7 million from the NIH’s Common Fund Venture Program to advance next-generation…
Genetic risk score can help identify women at higher risk of invasive breast cancer
Studying a person’s genetic makeup can predict if they will go on to develop invasive breast cancer after…
Radiomics significantly outperforms clinical models for predicting NPC treatment outcome
Nasopharyngeal carcinoma (NPC) is a highly aggressive malignancy, with most patients presenting at locally advanced stages. While immune…